Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer

NATerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 2, 2023

Study Completion Date

February 2, 2023

Conditions

Prostate Cancer

Interventions

DEVICE

ExAblate MRgFUS

ExAblate treatment of prostate cancer less than or equal to Grade 7

Trial Locations (4)

Beijing Hospital, Beijing

Changhai Hospital of Shanghai, Shanghai

Toronto General Hospital, Toronto

St. Mary's Hospital, London